← Alle mensen

WC

Wei Chua

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastati...

The Lancet. Oncology · 2025-03

Lu-PSMA-617 plus enzalutamide bij mCRPC: PSMAfore fase III

The Lancet. Oncology · 2024-05

OS met Lu-PSMA-617 versus cabazitaxel bij mCRPC: TheraP definitieve OS

The Lancet. Oncology · 2024-01

[177Lu]Lu-PSMA-617 versus cabazitaxel bij mCRPC: TheraP fase II

Lancet (London, England) · 27 februari 2021